PreventS-MD Ltd.

PreventS-MD: Digital Innovation for Chronic Disease Prevention 

A spin off from National Institute for Stroke and Applied Neurosciences (NISAN) and Auckland University of Technology (AUT) Ventures, New Zealand  that develops and commercialises digital technologies for preventing Stroke, Heart attack, Diabetes, Dementia and other chronic diseases. With globally recognised and clinically proven for promoting health and saving lives, and several global clinical studies proving it's  value. 

In AU and NZ healthcare systems and industry partners, it's also positioned as the primary destination for private and public healthcare data and reporting needs focusing on behavioral and other modifiable and non-modifiable risk factors contributing to lifestyle-related diseases, particularly where data collection is challenging and requires establishing strong relationships with data sources and need localised data collection methods.

It's flagship technology leverages the award-winning globally recognised technology endorsed by the World Health Organization (WHO) and accessible in 24 languages, potentially reaching over 5.3 billion people that recently won New Zealand Prime Minister’s award and WHO Digital Innovation award. 

Global Reach and Impact

Designed to reduce global chronic disease by 20% within 5 years through early risk detection and prevention strategies. Operates in NZ, Singapore, AU, Brazil, and ASEAN nations, developming globally scalable technologies for local healthcare needs.

PreventS-MD utilises a variety of business models:

1. Sharing costs of for research services and technology for private and public healthcare projects.

2. Revenue Sharing with healthcare platforms like Medtech Evolution and Indici.

3. Commission-Based Partnerships with pharmacies and online marketplaces.

Key Features

- Culturally Attuned

- Significant time and resource savings

- 300+ researchers, 27 govts, 30+ commercial entities.

- HIPAA, HL7, GDPR, Cybersecurity compliant and satisfy local regulations.